Cotinga Pharmaceuticals Inc.
COTQF · OTC
1/31/2020 | 10/31/2019 | 7/31/2019 | 4/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | -0.10 | 0.00 | -0.00 |
| FCF Yield | -34.83% | -35.36% | -128.63% | -41.01% |
| EV / EBITDA | -0.00 | -0.00 | -0.00 | -0.00 |
| Quality | ||||
| ROIC | 13.71% | 16.21% | 19.21% | -0.28% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.14 | 0.22 | 0.44 | 0.10 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 40.17% | 48.31% | -165.13% | -616.29% |
| Safety | ||||
| Net Debt / EBITDA | -0.00 | -0.00 | -0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |